Patent EP0288640A1 successfully refreshed from Google Patents.
EP0288640A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
6,11-Dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta-[1,2-b]pyridines and compositions and methods of use
Assignee: Merck Sharp & Dohme LLC
•
Filing: 1987-10-22
•
Granted: —
•
Expires: 2007-10-22
Abstract
Abstract Derivatives of 6,11-dihydro-11-(4-piperidylidene)-5 H -benzo[5,6]cyclohepta[1,2-b]pyridine, and pharmaceutically acceptable salts and solvates thereof are disclosed, which possess anti-allergic activity, making them effective as anti-allergic compounds. Methods for preparing and using the compounds are also described.
Inventors
- 👤 John J. Piwinsky
- 👤 Michael John Green
- 👤 Ashit Kumar Ganguly
- 👤 Jesse Kwok-Keung Wong
- 👤 Bernard Katchen
- 👤 Jeffrey Abbott Cramer
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-04 21:06
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/04; A; A61; A61P; A61P37/00; A61P37/08; A61P43/00
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
224 words
A compound represented by structural formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein: R represents H or alkyl, such that (1) when R represents alkyl, at least one of A and B represents a substituent group selected from H and OR¹, H and OC(O)R¹, =NOR¹ or -O-(CH₂) n -O-, and the other may represent H₂ or one of the above listed substituent groups; W, X, Y and Z may be the same or different and each independently represents H, halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -OR¹, -CO₂R¹ or -N(R¹)₂; R¹ is H, alkyl or aryl and in N(R¹)₂, R¹ can be alkanediyl, and n is 2, 3 or 4, and (2) when R represents H, A or B may be the same or different and each independently represents H₂, H and OR¹, H and OC(O)R¹, =O, =NOR¹ or -O-(CH₂) n -O-; W, X, Y and Z may be the same or different and each independently represents H, halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -OR¹ or -CO₂R¹ or -N(R¹)₂, with the provisos that when A and B both represent H₂, W is OR¹ and R¹ is H, and when A or B represents =O, at least one of W, X, Y and Z represents halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -OR¹, -CO₂R¹ or -N(R¹)₂; and R¹ and n are as defined above.
Claim 2
Dependent Claim
224 words
A compound represented by structural formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein: R represents H or alkyl, such that (1) when R represents alkyl, at least one of A and B represents a substituent group selected from H and OR¹, H and OC(O)R¹, =NOR¹ or -O-(CH₂) n -O-, and the other may represent H₂ or one of the above listed substituent groups; W, X, Y and Z may be the same or different and each independently represents H, halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -OR¹, -CO₂R¹ or -N(R¹)₂; R¹ is H, alkyl or aryl and in N(R¹)₂, R¹ can be alkanediyl, and n is 2, 3 or 4, and (2) when R represents H, A or B may be the same or different and each independently represents H₂, H and OR¹, H and OC(O)R¹, =O, =NOR¹ or -O-(CH₂) n -O-; W, X, Y and Z may be the same or different and each independently represents H, halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -OR¹ or -CO₂R¹ or -N(R¹)₂, with the provisos that when A and B both represent H₂, W is OR¹ and R¹ is H, and when A or B represents =O, at least one of W, X, Y and Z represents halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -OR¹, -CO₂R¹ or -N(R¹)₂; and R¹ and n are as defined above.
Claim 3
Dependent Claim
87 words
A compound as defined in claim 1 wherein R represents alkyl; at least one of A and B represents a substituent group selected from H and OR¹, H and OC(O)R¹, =NOR¹ or -O-(CH₂) n -O-, and the other may represent H₂ or one of the above listed substituent groups; W, X, Y and Z may be the same or different and each independently represents H, halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -CO₂R¹ or -N(R¹)₂; R¹ is H, alkyl or aryl and n is 2, 3 or 4.
Claim 4
Dependent Claim
113 words
A compound as defined in claim 1 wherein R represents H; A or B may be the same or different and each independently represents H₂, H and OR¹, H and OC(O)R¹, =O, =NOR¹ or -O-(CH₂) n -O-; W, X, Y and Z may be the same or different and each independently represents H, halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -OR¹ or -CO₂R¹ or -N(R¹)₂ with the provisos that when A and B both represent H₂, W is -OH, and when A or B represents =O, at least one of W, X, Y and Z represents halo, alkyl, -CF₃, -NO₂, -OC(O)R¹, -SR¹, -OR¹, -CO₂R¹ or -N(R¹)₂, and R¹ and n are as previously defined.
Claim 5
Dependent Claim
12 words
A compound as defined in claim 2 wherein R represents lower alkyl.
Claim 6
Dependent Claim
35 words
A compound as defined in any of claims 1-4 above wherein one of A and B is H₂ and the other of A and B represents H- and OC(O)R¹, =O, =NOR¹ or -O-(CH₂) n O-.
Claim 7
Dependent Claim
22 words
A compound as defined in any of claims 1-5 above wherein at least one of A and B represents H and OR¹.
Claim 8
Dependent Claim
20 words
A compound as defined in any of claims 1-6 above wherein A and B represent H₂, and W represents OR¹.
Claim 9
Dependent Claim
14 words
A compound as defined in any of claims 1-7 above wherein R¹ represents H.
Claim 10
Dependent Claim
26 words
A compound as defined in any of claims 1-8 above wherein W, X, Y and Z independently represent H, halo, alkyl, -CF₃, SR¹, -OR¹ or N(R¹)₂.
Claim 11
Dependent Claim
20 words
A compound as defined in any of claims 1-9 above wherein at least one of Y and Z represents halo.
Claim 12
Dependent Claim
17 words
A compound as defined in any of claims 1-10 above wherein W represents OR¹ at position 3.
Claim 13
Dependent Claim
20 words
A compound as defined in claim 1 having the following name: 8-chloro-11-[4-piperidylidene]-5,11-dihydro-6H-benzo[5,6]cyclohepta[1,2-b]pyridin-6-one; 6-hydroxy-8-chloro-11-[4-piperidylidene]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-chloro-6-hydroxyimino-11-[1-methyl-4-piperidylidine]-6H-benzo[5,6]cyclohepta[1,2-b]pyridine; 8-chloro-11-[1-methyl-4-piperidylidene]-5,11-dihydro-6H-benzo[5,6]-cyclohepta[1,2-b]pyridin-6-ol; 8-chloro-11-[1-methyl-4-piperidylidene]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-6-ol; 8-chloro-11-[4-piperidylidene]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-5-one; 5-hydroxy-8-chloro-11-(4-piperidylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; or 3-hydroxy-8-chloro-11-|4-piperidylidene]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine.
Claim 14
Dependent Claim
17 words
A pharmaceutical composition which comprises a compound of claim 1 in combination with a pharmaceutically acceptable carrier.
Claim 15
Independent Claim
19 words
A method of making a pharmaceutical composition comprising mixing a compound of formula I with a pharmaceutically acceptable carrier.
Claim 16
Independent Claim
19 words
A method of making a pharmaceutical composition comprising mixing a compound of formula I with a pharmaceutically acceptable carrier.
Claim 17
Dependent Claim
20 words
The use of a compound as claimed in claim 1 for the preparation of a pharmaceutical composition for anti-allergy application.
Claim 18
Dependent Claim
99 words
A process for producing a compound having structural formula I as defined in Claim 1 characterised by: a) decarboxylating a compound of the structure where R b is alkyl, or aryl; b) reducing the keto compound at the keto group, c) dealkylating a compound of the structure where R a is alkyl; or d) oral dosing a human and/or monkey with 8-chloro-6,11-dihydro-11-(1-ethoxycarbonyl-4-piperidylidene)- 5 H-benzo [5,6]cyclohepta[1,2-b]pyridine and isolating from the respective human and/or monkey urine; which processes may further comprise the step of converting one functional group of a compound of formula I into another functional group of formula I.
References Cited (Backward Citations)
US3326924A
Cited
DE1470314B2
Cited
US3717647A
Cited
US4282233A
Cited
EP0042544A2
Cited
US4355036A
Cited
US4282233B1
Cited
EP0152897A1
Cited
EP0208855A1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.